- Home
- FGL vs ANTX Comparison
FGL vs ANTX Comparison
Compare FGL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- ANTX
- Stock Information
- Founded
- FGL 2021
- ANTX 2017
- Country
- FGL Malaysia
- ANTX United States
- Employees
- FGL N/A
- ANTX N/A
- Industry
- FGL
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- ANTX Health Care
- Exchange
- FGL NYSE
- ANTX Nasdaq
- Market Cap
- FGL 25.4M
- ANTX 33.2M
- IPO Year
- FGL 2024
- ANTX 2022
- Fundamental
- Price
- FGL $0.94
- ANTX $1.10
- Analyst Decision
- FGL
- ANTX Buy
- Analyst Count
- FGL 0
- ANTX 2
- Target Price
- FGL N/A
- ANTX $2.00
- AVG Volume (30 Days)
- FGL 284.8K
- ANTX 95.4K
- Earning Date
- FGL 07-22-2025
- ANTX 08-12-2025
- Dividend Yield
- FGL N/A
- ANTX N/A
- EPS Growth
- FGL N/A
- ANTX N/A
- EPS
- FGL N/A
- ANTX N/A
- Revenue
- FGL $20,205,441.00
- ANTX N/A
- Revenue This Year
- FGL N/A
- ANTX N/A
- Revenue Next Year
- FGL N/A
- ANTX N/A
- P/E Ratio
- FGL N/A
- ANTX N/A
- Revenue Growth
- FGL N/A
- ANTX N/A
- 52 Week Low
- FGL $0.66
- ANTX $0.87
- 52 Week High
- FGL $5.26
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- ANTX 48.42
- Support Level
- FGL N/A
- ANTX $1.05
- Resistance Level
- FGL N/A
- ANTX $1.10
- Average True Range (ATR)
- FGL 0.00
- ANTX 0.04
- MACD
- FGL 0.00
- ANTX 0.00
- Stochastic Oscillator
- FGL 0.00
- ANTX 50.00
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.